Will NVIDIA Stock Bounce Back?
After the wild market moves during February and March, investors…
Sell
39
ARKK Quote, Financials, Valuation and Earnings
Last price:
$46.22
Seasonality move
:
10.62%
Day range:
$45.28 - $47.56
52-week range:
$36.85 - $68.43
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
8.8M
Avg. volume:
15.8M
1-year change:
-0.54%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ARKK
ARK Innovation ETF
|
-- | -- | -- | -- | -- |
|
ARKW
ARK Next Generation Internet ETF
|
-- | -- | -- | -- | -- |
|
BTX
Brooklyn ImmunoTherapeutics
|
-- | -- | -- | -- | -- |
|
IWP
iShares Russell Mid-Cap Growth ETF
|
-- | -- | -- | -- | -- |
|
VOT
Vanguard Mid-Cap Growth Index Fund ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ARKK
ARK Innovation ETF
|
$46.26 | -- | -- | -- | $0.00 | 0% | -- |
|
ARKW
ARK Next Generation Internet ETF
|
$92.81 | -- | -- | -- | $0.00 | 0% | -- |
|
BTX
Brooklyn ImmunoTherapeutics
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
IWP
iShares Russell Mid-Cap Growth ETF
|
$113.63 | -- | -- | -- | $0.10 | 0.43% | -- |
|
VOT
Vanguard Mid-Cap Growth Index Fund ETF
|
$235.61 | -- | -- | -- | $0.45 | 0.74% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ARKK
ARK Innovation ETF
|
-- | 2.712 | -- | -- |
|
ARKW
ARK Next Generation Internet ETF
|
-- | 2.412 | -- | -- |
|
BTX
Brooklyn ImmunoTherapeutics
|
-- | 0.000 | -- | -- |
|
IWP
iShares Russell Mid-Cap Growth ETF
|
-- | 1.435 | -- | -- |
|
VOT
Vanguard Mid-Cap Growth Index Fund ETF
|
-- | 1.248 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ARKK
ARK Innovation ETF
|
-- | -- | -- | -- | -- | -- |
|
ARKW
ARK Next Generation Internet ETF
|
-- | -- | -- | -- | -- | -- |
|
BTX
Brooklyn ImmunoTherapeutics
|
-- | -- | -- | -- | -- | -- |
|
IWP
iShares Russell Mid-Cap Growth ETF
|
-- | -- | -- | -- | -- | -- |
|
VOT
Vanguard Mid-Cap Growth Index Fund ETF
|
-- | -- | -- | -- | -- | -- |
ARK Innovation ETF vs. Competitors
-
Which has Higher Returns ARKK or ARKW?
ARK Next Generation Internet ETF has a net margin of -- compared to ARK Innovation ETF's net margin of --. ARK Innovation ETF's return on equity of -- beat ARK Next Generation Internet ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ARKKARK Innovation ETF-- -- -- ARKWARK Next Generation Internet ETF-- -- -- -
What do Analysts Say About ARKK or ARKW?
ARK Innovation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ARK Next Generation Internet ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ARK Innovation ETF has higher upside potential than ARK Next Generation Internet ETF, analysts believe ARK Innovation ETF is more attractive than ARK Next Generation Internet ETF.
Company Buy Ratings Hold Ratings Sell Ratings ARKKARK Innovation ETF0 0 0 ARKWARK Next Generation Internet ETF0 0 0 -
Is ARKK or ARKW More Risky?
ARK Innovation ETF has a beta of 2.054, which suggesting that the stock is 105.38% more volatile than S&P 500. In comparison ARK Next Generation Internet ETF has a beta of 1.972, suggesting its more volatile than the S&P 500 by 97.165%.
-
Which is a Better Dividend Stock ARKK or ARKW?
ARK Innovation ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ARK Next Generation Internet ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ARK Innovation ETF pays -- of its earnings as a dividend. ARK Next Generation Internet ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ARKK or ARKW?
ARK Innovation ETF quarterly revenues are --, which are smaller than ARK Next Generation Internet ETF quarterly revenues of --. ARK Innovation ETF's net income of -- is lower than ARK Next Generation Internet ETF's net income of --. Notably, ARK Innovation ETF's price-to-earnings ratio is -- while ARK Next Generation Internet ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ARK Innovation ETF is -- versus -- for ARK Next Generation Internet ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ARKKARK Innovation ETF-- -- -- -- ARKWARK Next Generation Internet ETF-- -- -- --
-
Which has Higher Returns ARKK or BTX?
Brooklyn ImmunoTherapeutics has a net margin of -- compared to ARK Innovation ETF's net margin of --. ARK Innovation ETF's return on equity of -- beat Brooklyn ImmunoTherapeutics's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ARKKARK Innovation ETF-- -- -- BTXBrooklyn ImmunoTherapeutics-- -- -- -
What do Analysts Say About ARKK or BTX?
ARK Innovation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Brooklyn ImmunoTherapeutics has an analysts' consensus of -- which suggests that it could fall by --. Given that ARK Innovation ETF has higher upside potential than Brooklyn ImmunoTherapeutics, analysts believe ARK Innovation ETF is more attractive than Brooklyn ImmunoTherapeutics.
Company Buy Ratings Hold Ratings Sell Ratings ARKKARK Innovation ETF0 0 0 BTXBrooklyn ImmunoTherapeutics0 0 0 -
Is ARKK or BTX More Risky?
ARK Innovation ETF has a beta of 2.054, which suggesting that the stock is 105.38% more volatile than S&P 500. In comparison Brooklyn ImmunoTherapeutics has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ARKK or BTX?
ARK Innovation ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Brooklyn ImmunoTherapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ARK Innovation ETF pays -- of its earnings as a dividend. Brooklyn ImmunoTherapeutics pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ARKK or BTX?
ARK Innovation ETF quarterly revenues are --, which are smaller than Brooklyn ImmunoTherapeutics quarterly revenues of --. ARK Innovation ETF's net income of -- is lower than Brooklyn ImmunoTherapeutics's net income of --. Notably, ARK Innovation ETF's price-to-earnings ratio is -- while Brooklyn ImmunoTherapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ARK Innovation ETF is -- versus -- for Brooklyn ImmunoTherapeutics. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ARKKARK Innovation ETF-- -- -- -- BTXBrooklyn ImmunoTherapeutics-- -- -- --
-
Which has Higher Returns ARKK or IWP?
iShares Russell Mid-Cap Growth ETF has a net margin of -- compared to ARK Innovation ETF's net margin of --. ARK Innovation ETF's return on equity of -- beat iShares Russell Mid-Cap Growth ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ARKKARK Innovation ETF-- -- -- IWPiShares Russell Mid-Cap Growth ETF-- -- -- -
What do Analysts Say About ARKK or IWP?
ARK Innovation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Russell Mid-Cap Growth ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ARK Innovation ETF has higher upside potential than iShares Russell Mid-Cap Growth ETF, analysts believe ARK Innovation ETF is more attractive than iShares Russell Mid-Cap Growth ETF.
Company Buy Ratings Hold Ratings Sell Ratings ARKKARK Innovation ETF0 0 0 IWPiShares Russell Mid-Cap Growth ETF0 0 0 -
Is ARKK or IWP More Risky?
ARK Innovation ETF has a beta of 2.054, which suggesting that the stock is 105.38% more volatile than S&P 500. In comparison iShares Russell Mid-Cap Growth ETF has a beta of 1.156, suggesting its more volatile than the S&P 500 by 15.594%.
-
Which is a Better Dividend Stock ARKK or IWP?
ARK Innovation ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. iShares Russell Mid-Cap Growth ETF offers a yield of 0.43% to investors and pays a quarterly dividend of $0.10 per share. ARK Innovation ETF pays -- of its earnings as a dividend. iShares Russell Mid-Cap Growth ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ARKK or IWP?
ARK Innovation ETF quarterly revenues are --, which are smaller than iShares Russell Mid-Cap Growth ETF quarterly revenues of --. ARK Innovation ETF's net income of -- is lower than iShares Russell Mid-Cap Growth ETF's net income of --. Notably, ARK Innovation ETF's price-to-earnings ratio is -- while iShares Russell Mid-Cap Growth ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ARK Innovation ETF is -- versus -- for iShares Russell Mid-Cap Growth ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ARKKARK Innovation ETF-- -- -- -- IWPiShares Russell Mid-Cap Growth ETF-- -- -- --
-
Which has Higher Returns ARKK or VOT?
Vanguard Mid-Cap Growth Index Fund ETF has a net margin of -- compared to ARK Innovation ETF's net margin of --. ARK Innovation ETF's return on equity of -- beat Vanguard Mid-Cap Growth Index Fund ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ARKKARK Innovation ETF-- -- -- VOTVanguard Mid-Cap Growth Index Fund ETF-- -- -- -
What do Analysts Say About ARKK or VOT?
ARK Innovation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Vanguard Mid-Cap Growth Index Fund ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ARK Innovation ETF has higher upside potential than Vanguard Mid-Cap Growth Index Fund ETF, analysts believe ARK Innovation ETF is more attractive than Vanguard Mid-Cap Growth Index Fund ETF.
Company Buy Ratings Hold Ratings Sell Ratings ARKKARK Innovation ETF0 0 0 VOTVanguard Mid-Cap Growth Index Fund ETF0 0 0 -
Is ARKK or VOT More Risky?
ARK Innovation ETF has a beta of 2.054, which suggesting that the stock is 105.38% more volatile than S&P 500. In comparison Vanguard Mid-Cap Growth Index Fund ETF has a beta of 1.157, suggesting its more volatile than the S&P 500 by 15.721%.
-
Which is a Better Dividend Stock ARKK or VOT?
ARK Innovation ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Vanguard Mid-Cap Growth Index Fund ETF offers a yield of 0.74% to investors and pays a quarterly dividend of $0.45 per share. ARK Innovation ETF pays -- of its earnings as a dividend. Vanguard Mid-Cap Growth Index Fund ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ARKK or VOT?
ARK Innovation ETF quarterly revenues are --, which are smaller than Vanguard Mid-Cap Growth Index Fund ETF quarterly revenues of --. ARK Innovation ETF's net income of -- is lower than Vanguard Mid-Cap Growth Index Fund ETF's net income of --. Notably, ARK Innovation ETF's price-to-earnings ratio is -- while Vanguard Mid-Cap Growth Index Fund ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ARK Innovation ETF is -- versus -- for Vanguard Mid-Cap Growth Index Fund ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ARKKARK Innovation ETF-- -- -- -- VOTVanguard Mid-Cap Growth Index Fund ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Energy Transfer a Good Dividend Stock to Buy Now?
Energy Transfer (NYSE:ET) offers an impressive yield, to say the…
Did the Market Bottom Already?
The past few weeks have been among the most volatile…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
47
RGC alert for Apr 15
Regencell Bioscience Holdings [RGC] is up 4.96% over the past day.
Sell
50
SLP alert for Apr 15
Simulations Plus [SLP] is down 1.02% over the past day.
Sell
46
ZLAB alert for Apr 15
Zai Lab [ZLAB] is down 1.21% over the past day.
